Skip to main content
Our Team
Our Technology
Pipeline
News
Publications
Partners & Investors
Careers
Contact
Contact
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
Let's talk
We would love to hear from you!
Get in touch